摘要
Background: Acute kidney injury (AKI) is a known complication of cisplatin administration; currently, there are no effective ways to prevent it. Therefore, it largely limited the use of cisplatin in chemotherapy in the clinic. In this study, we reported that Limonin, a triterpenoid compound extracted from citrus, alleviated cisplatin-induced AKI through metabolic reprogramming in the diseased kidneys. Methods: Cisplatin was employed to induce AKI in mice. Three groups were set up: Sham, cisplatin + vehicle, and cisplatin + Limonin. Using UHPLC-TOF/MS, we conducted metabolomics to profile the kidneys' endogenous metabolites and metabolic pathways. A network pharmacological method was performed to identify the targets of Limonin on AKI. The human proximal tubular epithelial cell line (HK-2) was applied for in vitro studies. Results: Limonin preserved serum creatinine and blood urea nitrogen levels after cisplatin-induced AKI. Employing metabolomics, we identified 33 endogenous differentially expressed metabolites and 7 significantly disturbed metabolic pathways in the diseased kidneys within three groups. After AKI, Limonin significantly reduced linoleic acid and its downstream product, arachidonic acid, thus exerting a protective effect on the kidney. The network pharmacological method identified CYP3A4 as a key target of Limonin in treating AKI, while CYP3A4 also serve as a mediator of arachidonic acid metabolism. In vitro, Limonin markedly reduced the level of arachidonic acid and HK-2 cell apoptosis triggered by cisplatin, mainly related to the targeted inhibition of CYP3A4-mediated arachidonic acid metabolism. Conclusion: Limonin ameliorates cisplatin-induced AKI by inhibiting CYP3A4 activity to regulate arachidonic acid metabolism, ultimately preserving kidney function.
学科与关键词
- Limonin ameliorates cisplatin-induced acute liver injury by inhibiting 11β-hydroxysteroid dehydrogenase type 1Xiang, Yadie; Zhou, Xianke; Zhou, Hong; Li, Dier; Zhong, Menghua; Hong, Xue; Song, Dongyan; Long, Yinyi; Zeng, Xi; Chen, Yudan; Zhou, Jiayi; Liang, Dongning; Fu, Haiyan*Biomedicine and Pharmacotherapy, 2023, 168: 115680.
- Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injuryZhou, Xianke; Xiang, Yadie; Li, Dier; Zhong, Menghua; Hong, Xue; Gui, Yuan; Min, Wenjian; Chen, Yudan; Zeng, Xi; Zhu, Haili; Liu, Youhua; Liu, Shijia; Yang, Peng; Hou, Fanfan; Zhou, Dong; Fu, HaiyanInternational Journal of Biological Sciences, 2023, 19(9): 2860-2878.被引 3
- Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosisXu, Zheming; Zhang, Minjing; Wang, Wenwen; Zhou, Suhan; Yu, Minghua; Qiu, Xingyu; Jiang, Shan; Wang, Xiaohua; Tang, Chun; Li, Shuijie; Wang, Chih-Hong; Zhu, Runzhi; Peng, Wan Xin; Zhao, Lin; Fu, Xiaodong; Patzak, Andreas; Persson, Pontus B.; Zhao, Liang; Mao, Jianhua; Shu, Qiang*; Lai, En Yin*; Zhang, Gensheng*Toxicology and Applied Pharmacology, 2023, 473: 116595.被引 5
